AndrewJHeadMDFACR

Clinical Trials

• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27

  Completed

  Phase 3

• A Study of LY3337641 in Rheumatoid Arthritis Start of enrollment: 2016 Aug 22

  Terminated

  Phase 2

• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis Start of enrollment: 2019 Apr 25

  Active, not recruiting

  Phase 4

• A Study in Moderate to Severe Rheumatoid Arthritis Participants Start of enrollment: 2012 Dec 01

  Completed

  Phase 3

• A Moderate to Severe Rheumatoid Arthritis Study Start of enrollment: 2013 Jan 01

  Completed

  Phase 3

• Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus Start of enrollment: 2016 Jun 30

  Completed

  Phase 3

• Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus Start of enrollment: 2015 Jun 09

  Completed

  Phase 3

• AMG 827 in Subjects With Psoriatic Arthritis Start of enrollment: 2011 Oct 01

  Terminated

  Phase 2

• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus Start of enrollment: 2010 Dec 01

  Completed

  Phase 3

• Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis Start of enrollment: 2008 Mar 01

  Terminated

  Phase 2

• Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) Start of enrollment: 2008 Oct 01

  Terminated

• Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) Start of enrollment: 2006 Mar 01

  Completed

  Phase 2

• A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus Start of enrollment: 2004 Oct 01

  Completed

  Phase 1

• Join now to see all